The Centers for Medicare & Medicaid Services' proposal for competitive acquisition of Part B-covered drugs requires "significant changes" to be effective, attorney Carolyn McElroy told an American Conference Institute/Pharmaceutical Care Management Association conference in Washington, D.C. April 18

U.S. Oncology plans to go private ahead of the 2005 reimbursement changes for chemotherapy drugs under the Medicare prescription drug law

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011